U.S. Markets open in 3 hrs 44 mins

Dynavax Technologies Corporation (DVAX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
10.40+0.50 (+5.05%)
At close: 4:00PM EDT
People also watch
NVAXFOLDACADARRYCLDX
Full screen
Previous Close9.90
Open8.95
Bid9.65 x 100
Ask12.40 x 500
Day's Range8.15 - 10.75
52 Week Range3.20 - 17.50
Volume10,707,889
Avg. Volume1,724,374
Market Cap569.38M
Beta0.24
PE Ratio (TTM)-3.70
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Why Dynavax Technologies Corporation Stock Is Slumping Today
    Motley Fool17 hours ago

    Why Dynavax Technologies Corporation Stock Is Slumping Today

    Safety issues continue to cast doubt on the future of Dynavax's experimental hepatitis B vaccine.

  • Reuters17 hours ago

    Dynavax hepatitis B vaccine works; raises safety issues -FDA

    Dynavax Technologies Corp's experimental hepatitis B vaccine is effective, but there were more deaths and serious heart problems in patients given the vaccine than in those given a rival product, according to a preliminary Food and Drug Administration report published on Wednesday. The review, posted on the FDA's website, comes two days ahead of a meeting of outside advisors who will discuss the vaccine, Heplisav-B, and recommend whether it should be approved. The FDA is not bound to follow the advice of its advisory panels but typically does so.

  • Reuters21 hours ago

    More deaths with Dynavax vaccine but overall rate low - FDA

    There were more deaths in patients taking Dynavax Technologies Corp's experimental hepatitis B vaccine than those taking a rival product, but the overall rate of death was low, a preliminary review by Food and Drug Administration reviewers concluded. The review, posted on Wednesday on the FDA's website, comes two days ahead of a meeting of outside advisors who will discuss the vaccine and recommend whether it should be approved. The FDA is not bound to follow the advice of its advisory panels but typically does so.